CS logo
small CS logo
Alfieri Cardiology

Newark, Delaware, United States
Cardiologist in New Castle County, Delaware
701 Foulk Rd Suite 1A, Wilmington, DE 19803

About Alfieri Cardiology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Lantheus Medical Imaging
4
Bristol-Myers Squibb
3
Point Biomedical
3
Pfizer
2
American Regent, Inc.
1
Amryt Pharma
1
Astellas Pharma Global Development, Inc.
1
Biotronik, Inc.
1
Bracco Diagnostics, Inc
1
Eisai Inc.
1
Gilead Sciences
1
Total Rows: 12

Clinical Trials at Alfieri Cardiology


During the past decade, Alfieri Cardiology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 10 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2200112200330022Started TrialsCompleted Trails201520162017201801234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response
2006-05-01
2010-12-01
Completed
1,491
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
2006-12-31
2011-05-25
Completed
20,976
Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent
2007-10-01
2008-07-01
Terminated
300
Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease
2006-11-01
2008-03-01
Completed
205
Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease
2007-10-01
2008-07-01
Terminated
1,000
A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice
2008-02-01
2009-07-01
Completed
1,060
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
2008-05-01
2012-08-01
Completed
2,711
Phase III Acute Coronary Syndrome
2009-03-01
2011-03-01
Terminated
7,484

Rows per page:

1–20 of 20

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Alfieri Cardiology" #1 sponsor was "Lantheus Medical Imaging" with 4 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Point Biomedical" with 3 trials sponsored, "Pfizer" with 2 trials sponsored and "American Regent, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Alfieri Cardiology" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsLantheus Medical Imaging: 4Lantheus Medical Imaging: 4Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3Point Biomedical: 3Point Biomedical: 3Pfizer: 2Pfizer: 2American Regent, Inc.: 1American Regent, Inc.: 1Amryt Pharma: 1Amryt Pharma: 1Astellas Pharma GlobalDevelopment, Inc.: 1Astellas Pharma GlobalDevelopment, Inc.: 1Biotronik, Inc.: 1Biotronik, Inc.: 1Bracco Diagnostics, Inc: 1Bracco Diagnostics, Inc: 1Eisai Inc.: 1Eisai Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsDuke Clinical ResearchInstitute: 2Duke Clinical ResearchInstitute: 2Pfizer: 2Pfizer: 2Syneos Health: 2Syneos Health: 2Thrombolysis InMyocardial Infarction(TIMI) AcademicResearch Organization:1Thrombolysis InMyocardial Infarction(TIMI) AcademicResearch Organization:1

Clinical Trials Conditions at Alfieri Cardiology


According to Clinical.Site data, the most researched conditions in "Alfieri Cardiology" are "Coronary Artery Disease" (5 trials), "Cardiovascular Disease" (4 trials), "Cardiac Disease" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Alfieri Cardiology" in a lesser frequency.

Clinical Trials Intervention Types at Alfieri Cardiology


Most popular intervention types in "Alfieri Cardiology" are "Drug" (18 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Apixaban" (2 trials), "DEFINITY®" (2 trials), "PB127 for Injectable Suspension" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Alfieri Cardiology


The vast majority of trials in "Alfieri Cardiology" are 20 trials for "All" genders.

Clinical Trials Status at Alfieri Cardiology


Currently, there are NaN active trials in "Alfieri Cardiology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Alfieri Cardiology, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Alfieri Cardiology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 12Phase 3: 12Phase 4: 4Phase 4: 4Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 13Completed: 13Terminated: 5Terminated: 5Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1